Carotid Stent Revenues to cross US$684 Million by 2012, According to New Report by Global Industry Analysts

Share Article

Carotid stents market, although in its infancy, is expected to witness gradual growth, driven primarily by the minimal-invasive nature of the method for treatment of carotid artery disease. World market for carotid stents in terms of revenues generated through carotid stent procedures is projected to total US$684 million by 2012.

Carotid Stents: A Global Strategic Business Report

Reduced procedure time, fewer complications, and shortened duration of patient hospitalization are few factors contributing to the growing utilization of carotid stenting procedures. Advent of advanced technologies for carotid stent systems is expected to lead to higher prices for products, thereby enhancing the revenue generation capacity of the market. The carotid artery stents market is also expected to benefit significantly from the expanded coverage for asymptomatic patients.

Total number of carotid stent procedures in the world is estimated at over 90 thousand for 2007, as stated in a recent report published by Global Industry Analysts, Inc. The United States garners the lion's share of the global market. The region is expected to witness rapid growth in revenue generation associated with carotid stenting. The availability of clinical data supporting the efficacy of CAS procedures is expected to accelerate FDA approvals of various products, thereby facilitating their faster commercialization and adoption. Carotid stent market in Europe is expected to reach US$92 million by 2009.

The market currently faces impediments in the form of insufficient reimbursement coverage, absence of trained physicians for performing the procedure, and absence of long-term scientific evidence for their use. Undiagnosed status of a majority of patients also contributes to gradual penetration of carotid stenting. Moreover, the presence of proven and efficient surgical procedures for low-risk patients impedes the widespread prevalence of stenting. With several ongoing large-scale clinical trials set to reach their conclusion, the positive outcomes of these trials would boost the penetration rate for carotid artery stenting (CAS).

Key players profiled in the study include Abbott Vascular, Boston Scientific Corporation, ev3, Inc., Johnson & Johnson, Kensey Nash Corporation, and Medtronic, Inc. More than 50% of the US market is currently held by Boston Scientific and Abbott Vascular.

The report titled "Carotid Stents: A Global Strategic Business Report" published by Global Industry Analysts, Inc., covers major market dynamics, trends, issues, and competition pertaining to the market. The report enumerates recent developments, mergers, acquisitions and other strategic industry activities. Analytics are provided for the period 2004-2012 in terms of both number of procedures and revenues generated. Geographic markets analyzed include the United States, Europe, and Rest of World.

For more details of this research report please visit

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs over 700 people worldwide and publishes more than 880 full-scale research reports each year. Additionally, the company also offers a range of over 60,000 smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.
Telephone 408-528-9966
Fax 408-528-9977
Web Site


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Public Relations
Visit website